Park Ha Biological Technology Co., Ltd. (PHH)

PHH Income Statement

Financials in millions USD. Fiscal year is November - October.

Year Ending	TTM	Oct 31, 2023	Oct 31, 2022
Revenue	1.94	2.46	1.92
Revenue Growth (YoY)	-	28.12%	-
Cost of Revenue	-	0.31	0.51
Gross Profit	1.66	2.15	1.41
Selling, General & Admin	-	0.78	1.15
Research & Development	-	0.03	0.06
Other Operating Expenses	0	0.15	0.01
Operating Expenses	-	0.97	1.21
Operating Income	0.6	1.18	0.2
Interest Expense / Income	-0	-0	-0
Other Expense / Income	0	0	0.01
Pretax Income	0.6	1.18	0.19
Income Tax	0.2	0.33	-0
Net Income	0.4	0.85	0.19
Net Income Growth	-	345.40%	-
Free Cash Flow	0.16	0.1	1.43
Gross Margin	85.36%	87.35%	73.47%
Operating Margin	30.82%	48.01%	10.26%
Profit Margin	20.67%	34.65%	9.97%
Free Cash Flow Margin	8.38%	4.22%	74.52%
Effective Tax Rate	32.85%	27.89%	-0.68%
EBITDA	0.62	1.2	0.22
EBITDA Margin	31.79%	48.80%	11.48%
Depreciation & Amortization	0.02	0.02	0.03
EBIT	0.6	1.18	0.19
EBIT Margin	30.68%	47.98%	9.90%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).